Based on the Medtronic PLC stock forecast from 15 analysts, the average analyst target price for Medtronic PLC is USD 94.97 over the next 12 months. Medtronic PLC’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Medtronic PLC is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, Medtronic PLC’s stock price was USD 81.37. Medtronic PLC’s stock price has changed by -2.64% over the past week, -7.04% over the past month and -2.03% over the last year.
No recent analyst target price found for Medtronic PLC
No recent average analyst rating found for Medtronic PLC
Company Overview Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland. Read Less
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchroniza...Read More
Frequently Asked Questions About Medtronic PLC (MDT) Stock
Based on ratings from 15 analysts Medtronic PLC's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 11 buy, sell and 19 hold ratings.
MDT stock's dividend yield is 3.20%.
Our analysis grades MDT stock's dividend yield at A+. This means that MDT stock's dividend yield is above 100% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this MDT may be a good dividend stock for its sector.
Based on targets from 15 analysts, the average taret price for MDT is USD 94.97 over the next 12 months. The maximum analyst target price is USD 109 while the minimum anlayst target price is USD 85.
MDT stock's Price/Earning ratio is 26.38.
Our analysis grades MDT stock's Price / Earning ratio at B-. This means that MDT stock's Price/Earning ratio is above 20% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this MDT may be undervalued for its sector.
The last closing price of MDT's stock was USD 81.37.
The most recent market capitalization for MDT is USD 110.62B.
Based on targets from 15 analysts, the average taret price for MDT is projected at USD 94.97 over the next 12 months.
This means that MDT's stock price may go up by +16.71% over the next 12 months.
We can't find any ETFs which contains Medtronic PLC's stock.
As per our most recent records Medtronic PLC has 95,000 Employees.
Medtronic PLC's registered address is Building Two, Galway, Ireland.
You can get more information about it from Medtronic PLC's website at https://www.medtronic.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Medtronic PLC (MDT) Stock
Based on ratings from 15 analysts Medtronic PLC's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 11 buy, sell and 19 hold ratings.
MDT stock's dividend yield is 3.20%.
Our analysis grades MDT stock's dividend yield at A+. This means that MDT stock's dividend yield is above 100% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this MDT may be a good dividend stock for its sector.
Based on targets from 15 analysts, the average taret price for MDT is USD 94.97 over the next 12 months. The maximum analyst target price is USD 109 while the minimum anlayst target price is USD 85.
MDT stock's Price/Earning ratio is 26.38.
Our analysis grades MDT stock's Price / Earning ratio at B-. This means that MDT stock's Price/Earning ratio is above 20% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this MDT may be undervalued for its sector.
The last closing price of MDT's stock was USD 81.37.
The most recent market capitalization for MDT is USD 110.62B.
Based on targets from 15 analysts, the average taret price for MDT is projected at USD 94.97 over the next 12 months.
This means that MDT's stock price may go up by +16.71% over the next 12 months.
We can't find any ETFs which contains Medtronic PLC's stock.
As per our most recent records Medtronic PLC has 95,000 Employees.
Medtronic PLC's registered address is Building Two, Galway, Ireland.
You can get more information about it from Medtronic PLC's website at https://www.medtronic.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MDT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
